AAAAAA
Results: 1-25/34
Authors:
Henlin, JM
Boutin, JA
Duchene-Roger, F
Nicolas, JP
Desmet-Beaufort, C
Levens, N
Fauchere, JL
Citation: Jm. Henlin et al., Parallel synthesis and pharmacological screening oi nonpeptide ligands of the neuropeptide Y receptor subtype Y-5, J PEPT RES, 57(5), 2001, pp. 419-427
Authors:
Henlin, JM
Boutin, JA
Kucharczyk, N
Desmet-Beaufort, C
Loynel, A
Bertrand, M
Genton, A
Tucker, GC
Atassi, G
Fauchere, JL
Citation: Jm. Henlin et al., From peptide libraries to optimized nonpeptide ligands in the search for S-farnesyltransferase inhibitors, J PEPT RES, 57(2), 2001, pp. 85-96
Authors:
Feletou, M
Lonchampt, M
Coge, F
Galizzi, JP
Bassoullet, C
Merial, C
Robineau, P
Boutin, JA
Huang, PL
Vanhoutte, PM
Canet, E
Citation: M. Feletou et al., Regulation of murine airway responsiveness by endothelial nitric oxide synthase, AM J P-LUNG, 281(1), 2001, pp. L258-L267
Authors:
Della Zuana, O
Sadlo, M
Germain, M
Feletou, M
Chamorro, S
Tisserand, F
de Montrion, C
Boivin, JF
Duhault, J
Boutin, JA
Levens, N
Citation: O. Della Zuana et al., Reduced food intake in response to CCP 71683A may be due to mechanisms other than NPYY5 receptor blockade, INT J OBES, 25(1), 2001, pp. 84-94
Authors:
Coge, F
Guenin, SP
Audinot, V
Renouard-Try, A
Beauverger, P
Macia, C
Ouvry, C
Nagel, N
Rique, H
Boutin, JA
Galizzi, JP
Citation: F. Coge et al., Genomic organization and characterization of splice variants of the human histamine H-3 receptor, BIOCHEM J, 355, 2001, pp. 279-288
Authors:
Ganguly, S
Gastel, JA
Weller, JL
Schwartz, C
Jaffe, H
Namboodiri, MAA
Coon, SL
Hickman, AB
Rollag, M
Obsil, T
Beauverger, P
Ferry, G
Boutin, JA
Klein, DC
Citation: S. Ganguly et al., Role of a pineal cAMP-operated arylalkylamine N-acetyltransferase/14-3-3-binding switch in melatonin synthesis (vol 98, pg 8083, 2001), P NAS US, 98(24), 2001, pp. 14186-14186
Authors:
Ganguly, S
Gastel, JA
Weller, JL
Schwartz, C
Jaffe, H
Namboodiri, MAA
Coon, SL
Hickman, AB
Rollag, M
Obsil, T
Beauverger, P
Ferry, G
Boutin, JA
Klein, DC
Citation: S. Ganguly et al., Role of a pineal cAMP-operated arylalkylamine N-acetyltransferase/14-3-3-binding switch in melatonin synthesis, P NAS US, 98(14), 2001, pp. 8083-8088
Authors:
Rodriguez, M
Beauverger, P
Naime, I
Rique, H
Ouvry, C
Souchaud, S
Dromaint, S
Nagel, N
Suply, T
Audinot, V
Boutin, JA
Galizzi, JP
Citation: M. Rodriguez et al., Cloning and molecular characterization of the novel human melanin-concentrating hormone receptor MCH2, MOLEC PHARM, 60(4), 2001, pp. 632-639
Authors:
Suply, T
Della Zuana, O
Audinot, V
Rodriguez, M
Beauverger, P
Duhault, J
Canet, E
Galizzi, JP
Nahon, JL
Levens, N
Boutin, JA
Citation: T. Suply et al., SLC-1 receptor mediates effect of melanin-concentrating hormone on feedingbehavior in rat: A structure-activity study, J PHARM EXP, 299(1), 2001, pp. 137-146
Authors:
Millan, MJ
Cussac, D
Milligan, G
Carr, C
Audinot, V
Gobert, A
Lejeune, F
Rivet, JM
Brocco, M
Duqueyroix, D
Nicolas, JP
Boutin, JA
Newman-Tancredi, A
Citation: Mj. Millan et al., Antiparkinsonian agent piribedil displays antagonist properties at native,rat, and cloned, human alpha(2)-adrenoceptors: Cellular and functional characterization, J PHARM EXP, 297(3), 2001, pp. 876-887
Authors:
Audinot, V
Beauverger, P
Lahaye, C
Suply, T
Rodriguez, M
Ouvry, C
Lamamy, V
Imbert, J
Rique, H
Nahon, JL
Galizzi, JP
Canet, E
Levens, N
Fauchere, JL
Boutin, JA
Citation: V. Audinot et al., Structure-activity relationship studies of melanin-concentrating hormone (MCH)-related peptide ligands at SLC-1, the human MCH receptor, J BIOL CHEM, 276(17), 2001, pp. 13554-13562
Authors:
Ferry, G
Bruneau, V
Beauverger, P
Goussard, M
Rodriguez, M
Lamamy, V
Dromaint, S
Canet, E
Galizzi, JP
Boutin, JA
Citation: G. Ferry et al., Binding of prostaglandins to human PPAR gamma: tool assessment and new natural ligands, EUR J PHARM, 417(1-2), 2001, pp. 77-89
Authors:
Ferry, G
Gillet, L
Bruneau, V
Banales, JM
Beauverger, P
Coge, F
Galizzi, JP
Scalbert, E
Okamoto, T
Urata, H
Boutin, JA
Citation: G. Ferry et al., Development of new assays and improved procedures for the purification of recombinant human chymase, EUR J BIOCH, 268(22), 2001, pp. 5885-5893
Authors:
Audinot, V
Lahaye, C
Suply, T
Beauverger, P
Rodriguez, M
Galizzi, JP
Fauchere, JL
Boutin, JA
Citation: V. Audinot et al., [I-125]-S36057: a new and highly potent radioligand for the melanin-concentrating hormone receptor, BR J PHARM, 133(3), 2001, pp. 371-378
Authors:
Nosjean, O
Nicolas, JP
Klupsch, F
Delagrange, P
Canet, E
Boutin, JA
Citation: O. Nosjean et al., Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2, BIOCH PHARM, 61(11), 2001, pp. 1369-1379
Authors:
Coge, F
Guenin, SP
Rique, H
Boutin, JA
Galizzi, JP
Citation: F. Coge et al., Structure and expression of the human histamine H-4-receptor gene, BIOC BIOP R, 284(2), 2001, pp. 301-309
Authors:
Ferry, G
Boutin, JA
Citation: G. Ferry et Ja. Boutin, High-capacity screening of arylalkylamine N-acetyltransferase inhibitors using a high-performance liquid chromatography system, J BIOMOL SC, 5(5), 2000, pp. 361-368
Authors:
Boutin, JA
Lahaye, C
Pegurier, C
Nicolas, JP
Fauchere, JL
Langlois, M
Renard, P
Delagrange, P
Canet, E
Citation: Ja. Boutin et al., Screening of ligand binding on melatonin receptor using non-peptide combinatorial libraries, J RECEPT SI, 20(1), 2000, pp. 105-118
Authors:
Pegurier, C
Curtet, S
Nicolas, JP
Boutin, JA
Delagrange, P
Renard, P
Langlois, M
Citation: C. Pegurier et al., Synthesis of a small library of phenylalkylamide derivatives as melatoninergic ligands for human mt(1) and MT2 receptors, BIO MED CH, 8(1), 2000, pp. 163-171
Authors:
Millan, MJ
Newman-Tancredi, A
Audinot, V
Cussac, D
Lejeune, F
Nicolas, JP
Coge, F
Galizzi, JP
Boutin, JA
Rivet, JM
Dekeyne, A
Gobert, A
Citation: Mj. Millan et al., Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT1B, 5-HT1D and dopamine D-2 and D-3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states, SYNAPSE, 35(2), 2000, pp. 79-95
Authors:
Cussac, D
Newman-Tancredi, A
Nicolas, JP
Boutin, JA
Millan, MJ
Citation: D. Cussac et al., Antagonist properties of the novel antipsychotic, S16924, at cloned, humanserotonin 5-HT2C receptors: a parallel phosphatidylinositol and calcium accumulation comparison with clozapine and haloperidol, N-S ARCH PH, 361(5), 2000, pp. 549-554
Authors:
Millan, MJ
Dekeyne, A
Newman-Tancredi, A
Cussac, D
Audinot, V
Milligan, G
Duqueyroix, D
Girardon, S
Mullot, J
Boutin, JA
Nicolas, JP
Renouard-Try, A
Lacoste, JM
Cordi, A
Citation: Mj. Millan et al., S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine, J PHARM EXP, 295(3), 2000, pp. 1192-1205
Authors:
Millan, MJ
Gobert, A
Newman-Tancredi, A
Lejeune, F
Cussac, D
Rivet, JM
Audinot, V
Adhumeau, A
Brocco, M
Nicolas, JP
Boutin, JA
Despaux, N
Peglion, JL
Citation: Mj. Millan et al., S18327 (1-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1) and alpha(2)-adrenergic receptors: I. Receptorial, neurochemical, and electrophysiological profile, J PHARM EXP, 292(1), 2000, pp. 38-53
Authors:
Jellimann, C
Mathe-Allainmat, M
Andrieux, J
Kloubert, S
Boutin, JA
Nicolas, JP
Bennejean, C
Delagrange, P
Langlois, M
Citation: C. Jellimann et al., Synthesis of phenalene and acenaphthene derivatives as new conformationally restricted ligands for melatonin receptors, J MED CHEM, 43(22), 2000, pp. 4051-4062
Authors:
Ferry, G
Loynel, A
Kucharczyk, N
Bertin, S
Rodriguez, M
Delagrange, P
Galizzi, JP
Jacoby, E
Volland, JP
Lesieur, D
Renard, P
Canet, E
Fauchere, JL
Boutin, JA
Citation: G. Ferry et al., Substrate specificity and inhibition studies of human serotonin N-acetyltransferase (vol 275, pg 8794, 2000), J BIOL CHEM, 275(50), 2000, pp. 39799-39799